A Boonen

Summary

Affiliation: University Hospital Maastricht
Country: The Netherlands

Publications

  1. pmc Rheumatism in the early 18th century: a doctor's diary
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 61:468-9. 2002
  2. pmc Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
    Ann Rheum Dis 64:396-402. 2005
  3. ncbi Everyone has the right to work
    Annelies Boonen
    J Rheumatol 32:571-4. 2005
  4. ncbi The burden of ankylosing spondylitis
    Annelies Boonen
    Department of Medicine, Division of Rheumatology, University Hospital Maastricht, and CAPHRI Research Institute, University of Maastricht, Maastricht, The Netherlands
    J Rheumatol Suppl 78:4-11. 2006
  5. ncbi Worker productivity outcome measures in arthritis
    Reuben Escorpizo
    Department of Rehabilitation Science, University of Toronto, and Institute for Work and Health, Toronto, Ontario, Canada
    J Rheumatol 34:1372-80. 2007
  6. pmc Expert agreement confirms that negative changes in hand and foot radiographs are a surrogate for repair in patients with rheumatoid arthritis
    Desiree van der Heijde
    Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Leiden 2300 RC, The Netherlands
    Arthritis Res Ther 9:R62. 2007
  7. pmc How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
    Annelies Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 66:771-7. 2007
  8. pmc Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 62:732-40. 2003
  9. pmc Costs of ankylosing spondylitis in three European countries: the patient's perspective
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 62:741-7. 2003
  10. ncbi A tale of two cities: hospitalization costs in 1897 and 1997
    Annelies Boonen
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    Int J Technol Assess Health Care 20:236-41. 2004

Collaborators

Detail Information

Publications64

  1. pmc Rheumatism in the early 18th century: a doctor's diary
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 61:468-9. 2002
  2. pmc Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
    Ann Rheum Dis 64:396-402. 2005
    ..To compare the cost of illness of three musculoskeletal conditions in relation to general wellbeing...
  3. ncbi Everyone has the right to work
    Annelies Boonen
    J Rheumatol 32:571-4. 2005
  4. ncbi The burden of ankylosing spondylitis
    Annelies Boonen
    Department of Medicine, Division of Rheumatology, University Hospital Maastricht, and CAPHRI Research Institute, University of Maastricht, Maastricht, The Netherlands
    J Rheumatol Suppl 78:4-11. 2006
    ..Early diagnosis and management of patients will likely prevent functional disability and improve patient outcomes...
  5. ncbi Worker productivity outcome measures in arthritis
    Reuben Escorpizo
    Department of Rehabilitation Science, University of Toronto, and Institute for Work and Health, Toronto, Ontario, Canada
    J Rheumatol 34:1372-80. 2007
    ..We recognize the need to perform psychometric testing of work outcome measures and to improve our ability to identify transitions (i.e., move in and out of a productivity state over time) made by workers with arthritis...
  6. pmc Expert agreement confirms that negative changes in hand and foot radiographs are a surrogate for repair in patients with rheumatoid arthritis
    Desiree van der Heijde
    Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Leiden 2300 RC, The Netherlands
    Arthritis Res Ther 9:R62. 2007
    ..The change in size of erosion was also picked up by independent readers applying the van der Heijde-modified Sharp scoring method and was reflected in their scores...
  7. pmc How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
    Annelies Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 66:771-7. 2007
    ..Purpose: To compare aspects of validity of EuroQol-5 Dimensions (EQ-5D) and Short-Form-6 Dimensions (SF-6D), two indirect utility instruments, and the well-being rating scale (RS) in ankylosing spondylitis (AS)...
  8. pmc Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 62:732-40. 2003
    ..To assess direct costs associated with ankylosing spondylitis (AS). To determine which variables, including country, predict costs...
  9. pmc Costs of ankylosing spondylitis in three European countries: the patient's perspective
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 62:741-7. 2003
    ..To assess a patient's out of pocket costs, income loss, time consumption, and quality of life (QoL) due to ankylosing spondylitis (AS) in three European countries and to assess variables predicting these outcomes...
  10. ncbi A tale of two cities: hospitalization costs in 1897 and 1997
    Annelies Boonen
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    Int J Technol Assess Health Care 20:236-41. 2004
    ..To compare the hospitalization day price, and the hospitalization costs 100 years ago with the present situation...
  11. pmc Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis?
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
    Ann Rheum Dis 63:1264-8. 2004
    ..To determine whether avoidant coping in ankylosing spondylitis (AS) is independent of disease status and whether it is stable over time...
  12. pmc Case number 33: about being a famous European and suffering from gout
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 64:528. 2005
  13. pmc Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands
    Ann Rheum Dis 65:201-8. 2006
    ..To estimate the incremental cost-utility of etanercept and infliximab compared with usual care in active ankylosing spondylitis...
  14. pmc Willingness of patients with ankylosing spondylitis to pay for inpatient treatment is influenced by the treatment environment and expectations of improvement
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 64:1650-2. 2005
    ..To assess the willingness to pay (WTP) for treatment in a spa resort of patients with ankylosing spondylitis (AS) and to assess if the experience of a spa influences the WTP...
  15. ncbi Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept
    Annelies Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, Maastricht, The Netherlands
    J Rheumatol 35:662-7. 2008
    ..To examine the longterm effect of etanercept (ETN) therapy on health-related quality of life (HRQOL) and utility in patients with ankylosing spondylitis...
  16. ncbi Conventional x-ray in early arthritis
    Annelies Boonen
    Division of Rheumatology, Department of Internal Medicine, University Hospital Maastricht Care and Public Health Research Institute, University Maastricht, P Debyelaan 25, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Rheum Dis Clin North Am 31:681-98. 2005
    ..The large number of patients with zero values for erosions and lower progression rates will influence sample sizes in clinical trials in early inflammatory arthritis when including radiographic change as an outcome...
  17. pmc "Allegory of the world": the ankylosed back as a metaphor for coping in daily life
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 65:852. 2006
  18. ncbi A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis
    Annelies Boonen
    Department of Internal Medicine, Division of Rheumatology and Caphri Research Institute, University Hospital Maastricht, The Netherlands
    Nat Clin Pract Rheumatol 2:546-53. 2006
    ..This article examines the effect of AS on work participation, costs of illness and reviews cost-effectiveness analyses of AS treatments...
  19. pmc Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 61:429-37. 2002
    ..To compare work disability, sick leave, and productivity costs due to ankylosing spondylitis (AS) of three European countries...
  20. pmc Colchicum autumnale from Het Cruydtboeck by Rembertus Dodonaeus
    A Boonen
    Department of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 61:492. 2002
  21. pmc Withdrawal from labour force due to work disability in patients with ankylosing spondylitis
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 60:1033-9. 2001
    ..To investigate withdrawal from the labour force because of inability to work owing to ankylosing spondylitis (AS) and to determine the characteristics of patients with no job because of work disability attributable to AS...
  22. ncbi Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review
    A Boonen
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    J Rheumatol 28:1056-62. 2001
    ..To evaluate work status and its determinants among patients with ankylosing spondylitis (AS)...
  23. pmc Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients
    A Boonen
    Department of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 60:353-8. 2001
    ..To evaluate employment status, work disability, and work days lost in patients with ankylosing spondylitis (AS)...
  24. ncbi Pericarditis after therapy with interferon-alpha for chronic hepatitis C
    A Boonen
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    Clin Rheumatol 18:177-9. 1999
    ..We report a patient with pericarditis following therapy with interferon-alpha for chronic hepatitis C viral infection. Possible relationships between pericarditis, hepatitis C and its treatment with interferon-alpha are briefly discussed...
  25. ncbi Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis
    L C Franke
    Maastricht University, CAPHRI Institute, Faculty of Health Medicine and Life Sciences, Department of Health Organisation Policy and Economics, Maastricht, The Netherlands
    Clin Exp Rheumatol 27:S118-23. 2009
    ..To assess, quantify and summarise the cost of illness of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) from the societal perspective...
  26. ncbi Socioeconomic consequences of ankylosing spondylitis
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Clin Exp Rheumatol 20:S23-6. 2002
    ..A cost-effectiveness study on spa-therapy in AS shows that the clinical benefits of (expensive) treatments can be reached within acceptable costs...
  27. doi A review of instruments to assess illness representations in patients with rheumatic diseases
    M Maas
    Faculty of Medicine, University of Maastricht, Maastricht, The Netherlands
    Ann Rheum Dis 68:305-9. 2009
    ..Critical appraisal of instruments to assess illness representations in rheumatology...
  28. doi ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health
    A Boonen
    Maastricht University Medical Centre, Department of Internal Medicine, Division of Rheumatology, P Debyelaan 25, 6229 HX Maastricht, The Netherlands
    Ann Rheum Dis 69:102-7. 2010
    ....
  29. ncbi The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis
    A Boonen
    Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht, The Netherlands
    Clin Exp Rheumatol 27:S112-7. 2009
    ..However, since AS starts at an earlier age, the lifetime economic burden might be higher. There is a strong relation between physical function and each aspect of economic impact...
  30. ncbi Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis
    Astrid van Tubergen
    University Hospital Maastricht, Maastricht, The Netherlands
    Arthritis Rheum 47:8-16. 2002
    ....
  31. pmc Safety and patient satisfaction of infliximab administration in an extramural setting supervised by a rheumatology specialist nurse
    Y van Eijk
    Department of Integrated Care, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Ann Rheum Dis 65:276. 2006
  32. ncbi Contribution of progression of erosive damage in previously eroded joints in early rheumatoid arthritis trials: COBRA trial as an example
    Karin Bruynesteyn
    University of Maastricht, Maastricht, The Netherlands
    Arthritis Rheum 47:532-6. 2002
    ..The aim of this study is to evaluate the relative contribution of separate components of the erosion score of the modified Sharp/van der Heijde method in early RA...
  33. ncbi COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention
    Robert B M Landewe
    Department of Internal Medicine Rheumatology, PO Box 5800, University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands
    Arthritis Rheum 46:347-56. 2002
    ..The current study was conducted to investigate whether the benefits of COBRA therapy were sustained over time, and to determine which baseline factors could predict outcome...
  34. ncbi Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequence
    Karin Bruynesteyn
    Division of Rheumatology, Maastricht University, Maastricht, The Netherlands
    J Rheumatol 29:2306-12. 2002
    ....
  35. ncbi Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference
    Karin Bruynesteyn
    Maastricht University, Maastricht, The Netherlands
    Arthritis Rheum 46:913-20. 2002
    ....
  36. doi The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review
    M M Ter Wee
    Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands
    Ann Rheum Dis 71:161-71. 2012
    ..The effect on employment status was more conflicting, but 50% of studies that addressed patients with early methotrexate-naive RA showed a positive result on employment status...
  37. ncbi Rhemulatologists' performance in dailiy practice
    S Gorter
    Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Arthritis Rheum 45:16-27. 2001
    ..47; P < 0.05). CONCLUSION: A considerable variation in resource utilization was found among 27 Dutch rheumatologists. The information obtained is an excellent source for discussion on the appropriateness of care...
  38. ncbi Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts
    K Bruynesteyn
    Department of Rheumatology, University Hospital Maastricht, The Netherlands
    J Rheumatol 28:904-10. 2001
    ..The SDD is a conservative estimate of the MCID; our panel rated progression at or below this level as clinically significant...
  39. pmc An unusual case of ANCA positive disease
    S Delen
    Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands
    Ann Rheum Dis 62:780-1. 2003
  40. ncbi Ankylosing spondylitis: what is the cost to society, and can it be reduced?
    A Boonen
    Department of Rheumatology, University Hospital Maastricht, The Netherlands
    Best Pract Res Clin Rheumatol 16:691-705. 2002
    ....
  41. doi Physical activity and body composition in patients with ankylosing spondylitis
    G Plasqui
    Maastricht University Medical Centre, Maastricht, The Netherlands
    Arthritis Care Res (Hoboken) 64:101-7. 2012
    ..Accurate data are needed on body composition and physical activity in this patient group. The purpose of this study was to investigate body composition and objectively assessed physical activity in patients with AS...
  42. doi Which aspects of functioning are relevant for patients with ankylosing spondylitis: results of focus group interviews
    Annelies Boonen
    Department of Internal Medicine, Division of Rheumatology and Caphri Research Institute, Maastricht University Medical Center, Maastricht, The Netherlands
    J Rheumatol 36:2501-11. 2009
    ..To investigate whether concepts important to patients with ankylosing spondylitis (AS) are covered by disease-specific self-report health status instruments...
  43. doi Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost
    Annelies Boonen
    Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, P Debyelaan 25, Maastricht 6229HX, The Netherlands
    Ann Rheum Dis 69:1123-8. 2010
    ..To describe the influence of ankylosing apondylitis (AS) on sick leave, presenteeism and unpaid work restrictions and to estimate related productivity costs...
  44. doi Aspects relevant for functioning in patients with ankylosing spondylitis according to the health professionals: a Delphi study with the ICF as reference
    Annelies Boonen
    Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands
    Rheumatology (Oxford) 48:997-1002. 2009
    ..This study aimed to achieve consensus among health professionals on which aspects of functioning are typical and relevant for AS patients using the International Classification of Functioning, Disability and Health (ICF) as reference...
  45. ncbi Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial
    Astrid van Tubergen
    University Hospital Maastricht, Maastricht, The Netherlands
    Arthritis Rheum 47:459-67. 2002
    ....
  46. doi The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies
    Manuela Joore
    Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands
    Value Health 13:222-9. 2010
    ..This article investigates whether differences in utility scores based on the EQ-5D and the SF-6D have impact on the incremental cost-utility ratios in five distinct patient groups...
  47. ncbi The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study
    Annelies Boonen
    Department of Rheumatology, University Hospital Maastricht, University Maastricht, The Netherlands
    Inflamm Bowel Dis 8:382-9. 2002
    ..Inflammatory bowel diseases are chronic conditions that might cause a severe impact on social life. The aim of the study was to assess employment, chronic work disability, and sick leave in patients with inflammatory bowel disease...
  48. doi Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome
    Annelies Boonen
    University Hospital, Maastricht, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    J Rheumatol 36:1249-55. 2009
    ..To determine which patients with ankylosing spondylitis (AS) have radiographic spinal damage and to investigate the relation between radiographic spinal changes and limitations in physical function...
  49. doi The OMERACT-ICF Reference Group: integrating the ICF into the OMERACT process: opportunities and challenges
    Annelies Boonen
    Maastricht University Medical Centre, Department of Internal Medicine, Division of Rheumatology, Maastricht, The Netherlands
    J Rheumatol 36:2057-60. 2009
    ..Most members had experience with the ICF and worked further to integrate the ICF into OMERACT. We describe the main roles of the ICF in the OMERACT process and the challenges when practice confronts theory...
  50. pmc The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice
    Bert Vander Cruyssen
    Rheumatology Department, Ghent University Hospital, De Pintelaan 185, 90000 Ghent, Belgium
    Ann Rheum Dis 66:1072-7. 2007
    ....
  51. ncbi Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial
    Björn Svensson
    University of Lund, Lund, Sweden
    Arthritis Rheum 52:3360-70. 2005
    ..To assess the efficacy of low-dose prednisolone on joint damage and disease activity in patients with early rheumatoid arthritis (RA)...
  52. ncbi High work disability rate among rheumatoid arthritis patients in Lithuania
    Jolanta Dadoniene
    Institute of Experimental adn Clinical Medicine, Vilnius University, Vilnius, Lithuania
    Arthritis Rheum 51:433-9. 2004
    ..To assess if Lithuania's transition from a state-planned to a free-market economy after 1990 changed the employment perspectives of patients with RA...
  53. ncbi Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study
    Patrick Garnero
    INSERM Research Unit 403, and Synarc, Lyon, France
    Arthritis Rheum 46:2847-56. 2002
    ....
  54. ncbi Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone
    Ingeborg Korthals-de Bos
    Institute for Research in Extramural Medicine, VU University Medical Center, Amsterdam, The Netherlands
    J Rheumatol 31:1709-16. 2004
    ..Analyses of the efficacy and direct costs of the treatments have already been reported...
  55. doi Measuring health in patients with fibromyalgia: content comparison of questionnaires based on the International Classification of Functioning, Disability and Health
    Birgit Prodinger
    Vienna University, Department of Internal Medicine III, Division of Rheumatology, Vienna, Austria
    Arthritis Rheum 59:650-8. 2008
    ....
  56. ncbi Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis
    Walter P Maksymowych
    University of Alberta, Edmonton, Canada
    Arthritis Rheum 57:133-9. 2007
    ..We explored contributors to PASS, validated the PASS concept, and assessed thresholds of self-reported outcomes below which patients considered themselves in PASS...
  57. ncbi The World Health Organisation International Classification of Functioning, Disability and Health: a conceptual model and interface for the OMERACT process
    Gerold Stucki
    Department of Physical Medicine and Rehabilitation, University Hospital Munich, Ludwig Maximilian University Munich, Germany
    J Rheumatol 34:600-6. 2007
    ....
  58. ncbi The international classification for functioning, disability and health. A challenge and a need for rheumatology
    Annelies Boonen
    Clin Rheumatol 26:1803-8. 2007
  59. ncbi Fibromyalgia syndrome
    Philip Mease
    Seattle Rhumatology Associates, Seattle, WA 98104, USA
    J Rheumatol 34:1415-25. 2007
    ..The OMERACT process has provided a framework for identification of key domains to be assessed and a path toward validation and standardization of outcome measures for clinical trials in FM...
  60. pmc Reliability of the ICF Core Set for rheumatoid arthritis
    Till Uhlig
    National Resource Center for Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, Postboks 23 Vinderen, N 0319 Oslo, Norway
    Ann Rheum Dis 66:1078-84. 2007
    ..The comprehensive ICF Core Set for rheumatoid arthritis (RA) is a selection of 96 categories from the International Classification of Functioning, Disability and Health (ICF), representing relevant aspects in the functioning of RA patients...
  61. ncbi Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health
    Irene van Echteld
    Department of Physical Medicine and Rehabilitation, Ludwig Maximilians University, Munich, Germany
    J Rheumatol 33:2475-83. 2006
    ..We identified the common health problems of patients with ankylosing spondylitis (AS) based on the ICF from the perspective of the patient...
  62. ncbi The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks
    Tjeerd Peter van Staa
    Utrecht University, Utrecht, The Netherlands
    Value Health 10:348-57. 2007
    ..A pharmaco-economic model that used individualized risks for fractures was developed in order to take into account patient heterogeneity...
  63. ncbi Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis
    Nick Bansback
    Centre for Health Evaluation and Outcome Sciences, St Paul s Hospital, Vancouver, British Columbia, Canada
    J Rheumatol 34:1178-83. 2007
    ..Ten methodological issues are presented that will be important for future development of evaluations. Tentative proposals to define the issues in a reference case for AS are made, along with recommendations for further research...
  64. ncbi Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of Erosions
    John T Sharp
    University of Washington, Seattle, Washington, USA
    J Rheumatol 30:1102-7. 2003
    ..This study provides evidence that repair of bone damage in RA does occur, resulting in some degree of improvement, which was recognized by a majority of a panel of experts...